Adamis Pharmaceuticals has developed a prefilled epinephrine syringe as a cost-effective alternative to the automatic injectors. Currently, the only two available injections for epinephrine to treat severe allergic reactions are Epipen and Auvi=Q. Both work automatically to insert the needle and then deliver the medicine. However, both are expensive and cost constraints have led to some adults and children going without the protection.
The new prefilled syringe requires the patient or a caregiver to remove the needle shield, insert the needle into a muscle, then push the syringe to deliver the medicine and finally to remove the needle.
When studies were conducted on volunteers with no medical background 99% were able to successfully administer the medicine. This new tool called “Symjepi” has been FDA approved and provides a cost saving alternative to the auto-injectors.